Why Lantheus Holdings, Inc. (LNTH) Nosedived on Wednesday

We recently published an article titled Why These 10 Firms Nosedived Today. In this article, we are going to take a look at where Lantheus Holdings, Inc. (NASDAQ:LNTH) stands against the other stocks.

The stock market bounced back from the previous day’s losses, with all major indices finishing higher as investors cheered the central bank's decision to keep interest rates unchanged.

On Wednesday afternoon, the Federal Reserve kept rates steady at a range of 4.25 percent to 4.5 percent, saying that it was not in a hurry to cut rates and could still “wait and see” the impacts of President Donald Trump’s tariff policies.

The Dow Jones rallied by 0.70 percent, the S&P 500 increased by 0.43 percent, and the Nasdaq grew by 0.27 percent.

Beyond the major indices, bucked a broader market optimism as investors sold off on a series of disappointing news.

To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.

Lantheus Holdings, Inc. (NASDAQ:LNTH)

Lantheus Holdings, Inc. (NASDAQ:LNTH) declined for a third consecutive day on Wednesday, losing 23.23 percent to finish at $80.49 each as investors soured on the company’s lower revenue guidance for the rest of the year, coupled with a disappointing earnings performance.

In a statement, Lantheus Holdings, Inc. (NASDAQ:LNTH) said it now expects revenues for full-year 2025 to end between $1.55 billion and $1.585 billion, lower than the $1.545 billion to $1.61 billion as projected previously.

Adjusted EPS was also pegged at $6.6 to $6.7 versus the $7 to $7.2 previously.

In the first quarter, Lantheus Holdings, Inc. (NASDAQ:LNTH) reported a 44.3 percent lower net income of $72.9 million versus $131.1 million in the same period last year.

Revenues also ended at $372.8 million, relatively flat from $370 million in the same comparable period.

Lantheus Holdings, Inc. (NASDAQ:LNTH) is one of the leading radiopharmaceutical-focused companies with products across three categories: radiopharmaceutical oncology, precision diagnostics, and strategic partnerships.

Overall LNTH ranks 1st on our list of Wednesday's worst performers. While we acknowledge the potential of LNTH as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than LNTH but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.